Mersana Therapeutics Inc (MRSN)

01:47 AM

Day One to buy Mersana Therapeutics for $25/share upfront - MSN

01:47 AM

01:43 AM

Is Mersana Therapeutics Inc. (0M4) stock prepared for digital transitionRate Hike & Daily Growth Stock Investment Tips - Newser

01:43 AM

Dec 04, 2025

Can Mersana Therapeutics Inc. (0M4) stock stage a strong rebound this quarter - Newser

Dec 04, 2025

Dec 04, 2025

Can Mersana Therapeutics Inc. (0M4) stock sustain breakout momentumJuly 2025 PreEarnings & High Accuracy Investment Entry Signals - Newser

Dec 04, 2025

Dec 04, 2025

Why Mersana Therapeutics Inc. (0M4) stock could be next leaderJuly 2025 Opening Moves & Community Consensus Stock Picks - Newser

Dec 04, 2025

Dec 03, 2025

How Mersana Therapeutics Inc. (0M4) stock compares with top peersQuarterly Earnings Summary & Fast Gain Stock Trading Tips - Newser

Dec 03, 2025

Dec 02, 2025

Will Mersana Therapeutics Inc. (0M4) stock attract long term capital inflowsJuly 2025 Review & Consistent Income Trade Ideas - Newser

Dec 02, 2025

Dec 02, 2025

Will Mersana Therapeutics Inc. (0M4) stock deliver compounding returnsQuarterly Trade Report & Breakout Confirmation Alerts - Newser

Dec 02, 2025

Dec 02, 2025

Mersana Therapeutics, Inc. (NASDAQ:MRSN) Given Consensus Recommendation of "Reduce" by Brokerages - MarketBeat

Dec 02, 2025

Nov 30, 2025

Options Flow: How Mersana Therapeutics Inc. (0M4) stock compares with market leadersJuly 2025 Setups & Daily Technical Forecast Reports - BỘ NỘI VỤ

Nov 30, 2025

Nov 30, 2025

How Mersana’s Acquisition Is Changing the Story and Analyst Outlook for Investors - Yahoo Finance

Nov 30, 2025

Nov 28, 2025

Halper Sadeh LLC Encourages SEMR, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights - Sahm

Nov 28, 2025

Nov 28, 2025

HAPPY THANKSGIVING AND INVESTOR ALERT: The M&A Class Action Firm Continues to Investigate the MergerEXAS, SEE, CDTX, and MRSN - The Malaysian Reserve

Nov 28, 2025

Nov 27, 2025

Halper Sadeh LLC Encourages SEE, EXAS, MRSN Shareholders to Contact the Firm to Discuss Their Rights - GlobeNewswire Inc.

Nov 27, 2025

Nov 27, 2025

Is Mersana Therapeutics Inc. (0M4) stock a buy before new product rolloutJuly 2025 Rallies & Risk Controlled Daily Plans - BỘ NỘI VỤ

Nov 27, 2025

Nov 26, 2025

ENN Energy Holdings Announces Conditional Privatization Proposal - The Globe and Mail

Nov 26, 2025

Nov 25, 2025

683 Capital Management, LLC Increases Stake in Mersana Therapeutics Inc. - GuruFocus

Nov 25, 2025

Nov 21, 2025

Can Mersana Therapeutics Inc. (0M4) stock test all time highsJuly 2025 Macro Moves & Free Reliable Trade Execution Plans - newser.com

Nov 21, 2025

Nov 20, 2025

Will Mersana Therapeutics Inc. stock outperform Dow Jones indexJuly 2025 Trade Ideas & Safe Capital Growth Stock Tips - newser.com

Nov 20, 2025

Nov 20, 2025

Is Mersana Therapeutics Inc. (0M4) stock testing key supportEarnings Risk Report & AI Driven Stock Reports - newser.com

Nov 20, 2025

Nov 19, 2025

Does Mersana Therapeutics Inc. qualify in momentum factor screeningShort Setup & Low Drawdown Momentum Ideas - newser.com

Nov 19, 2025

Nov 19, 2025

Why Mersana Therapeutics Inc. stock remains a top recommendationEarnings Miss & Free Reliable Trade Execution Plans - newser.com

Nov 19, 2025

Nov 19, 2025

Earnings visualization tools for Mersana Therapeutics Inc.2025 Risk Factors & Safe Swing Trade Setup Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

Will Mersana Therapeutics Inc. stock benefit from infrastructure spending2025 Analyst Calls & Safe Entry Point Alerts - newser.com

Nov 19, 2025

Nov 19, 2025

How Mersana Therapeutics Inc. (0M4) stock reacts to weak economyTrade Exit Summary & Safe Capital Growth Tips - newser.com

Nov 19, 2025

Nov 18, 2025

Detecting price anomalies in Mersana Therapeutics Inc. with AIWeekly Trade Report & Low Risk Entry Point Guides - newser.com

Nov 18, 2025

Nov 18, 2025

Using data filters to optimize entry into Mersana Therapeutics Inc.Weekly Investment Summary & Low Risk Entry Point Guides - newser.com

Nov 18, 2025